C-reactive protein is elevated in schizophrenia

Schizophrenia Research - Tập 143 - Trang 198-202 - 2013
Faith Dickerson1, Cassie Stallings1, Andrea Origoni1, Crystal Vaughan1, Sunil Khushalani1, Shuojia Yang2, Robert Yolken2
1Stanley Research Program, Sheppard Pratt, Baltimore, MD 21204, United States
2Stanley Neurovirology Laboratory, Johns Hopkins School of Medicine, Baltimore, MD 21207, United States

Tài liệu tham khảo

Akanji, 2009, Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients, Psychiatry Res., 169, 56, 10.1016/j.psychres.2008.06.010 Azar, 2011, Comparison of the effects of combination atorvastatin (40mg)+ezetimibe (10mg) versus atorvastatin (40mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent, Am. J. Cardiol., 107, 1571, 10.1016/j.amjcard.2011.01.038 Brown, 2011, The environment and susceptibility to schizophrenia, Prog. Neurobiol., 93, 23, 10.1016/j.pneurobio.2010.09.003 de Leon, 2005, A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors, Schizophr. Res., 76, 135, 10.1016/j.schres.2005.02.010 Diaz, 2010, Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample, Schizophr. Res., 121, 207, 10.1016/j.schres.2010.06.002 Dickerson, 2003, Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia, Arch. Gen. Psychiatry, 60, 466, 10.1001/archpsyc.60.5.466 Dickerson, 2007, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 952, 10.1016/j.pnpbp.2007.02.018 Dickerson, 2008, Association between cognitive functioning, exposure to herpes simplex virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder, Brain Behav. Immun., 22, 1103, 10.1016/j.bbi.2008.04.156 Dickerson, 2010, Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia, Biol. Psychiatry, 68, 100, 10.1016/j.biopsych.2010.03.021 Dieset, 2012, Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein, Schizophr. Res., 140, 169, 10.1016/j.schres.2012.06.040 Fawzi, 2011, C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia, Psychiatry Res., 190, 91, 10.1016/j.psychres.2011.05.010 Fernandez-Egea, 2009, Metabolic profile of antipsychotic-naive individuals with non-affective psychosis, Br. J. Psychiatry, 194, 434, 10.1192/bjp.bp.108.052605 First, 1996 First, 1998 Gejman, 2011, Genetics of schizophrenia: new findings and challenges, Annu. Rev. Genomics Hum. Genet., 12, 121, 10.1146/annurev-genom-082410-101459 Hope, 2009, Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor, Bipolar Disord., 11, 726, 10.1111/j.1399-5618.2009.00757.x Kay, 1991 Khera, 2005, Race and gender differences in C-reactive protein levels, J. Am. Coll. Cardiol., 46, 464, 10.1016/j.jacc.2005.04.051 Lowe, 2005, Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease, J. Thromb. Haemost., 1618, 10.1111/j.1538-7836.2005.01416.x Megna, 2011, Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions, Ann. Clin. Psychiatry, 23, 131 Meyer, 2009, Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study, Biol. Psychiatry, 66, 1013, 10.1016/j.biopsych.2009.06.005 Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013 Muller, 2000, The immune system and schizophrenia: an integrative view, Ann. N. Y. Acad. Sci., 917, 456, 10.1111/j.1749-6632.2000.tb05410.x Osman, 2006, Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease, Vasc. Health Risk Manag., 2, 221, 10.2147/vhrm.2006.2.3.221 Park, 2005, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6, Diabetes Res. Clin. Pract., 69, 29, 10.1016/j.diabres.2004.11.007 Rexrode, 2003, Relationship of total and abdominal adiposity with CRP and IL-6 in women, Ann. Epidemiol., 13, 674, 10.1016/S1047-2797(03)00053-X Richard, 2012, Schizophrenia and the immune system: pathophysiology, prevention, and treatment, Am. J. Health Syst. Pharm., 69, 757, 10.2146/ajhp110271 Rubin, 1996, Multiple imputation after 18+ years, J. Am. Stat. Assoc., 91, 473, 10.1080/01621459.1996.10476908 Sharpe, 2009, Low-fat oxidation may be a factor in obesity among men with schizophrenia, Acta Psychiatr. Scand., 119, 451, 10.1111/j.1600-0447.2008.01342.x Sicras-Mainar, 2011, C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice, Eur. Psychiatry, 10.1016/S0924-9338(11)73192-3 Suvisaari, 2011, Inflammation in psychotic disorders: a population-based study, Psychiatry Res., 189, 305, 10.1016/j.psychres.2011.07.006 Tandon, 2008, Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology, Schizophr. Res., 102, 1, 10.1016/j.schres.2008.04.011 The International Schizophrenia Consortium, 2009, Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, 460, 748, 10.1038/nature08185 Wannamethee, 2005, Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, Eur. Heart J., 26, 1765, 10.1093/eurheartj/ehi183 Wener, 2000, The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration, J. Rheumatol., 27, 2351 Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler. Thromb. Vasc. Biol., 19, 972, 10.1161/01.ATV.19.4.972